Latest Tuberculosis vaccines Stories
A new vaccine considered to be the most advanced for tuberculosis among more than a dozen now in trials has failed its study. Researchers said they were disappointed by the results of the study, which showed that the vaccine offered little to no protection at all from TB.
Cases of one of the world's deadliest diseases—tuberculosis—are rising at an alarming rate, despite widespread vaccination.
In this week's PLoS Medicine, and to coincide with World TB Day, Madhukar Pai from McGill University in Montreal, Canada and colleagues introduce the BCG World Atlas, an open access, user friendly website for TB clinicians to discern global BCG vaccination policies and practices and improve the care of their patients.
The University of Oxford and Emergent BioSolutions have formed a joint venture, The Oxford-Emergent Tuberculosis Consortium, to further develop MVA85A, a clinically advanced vaccine candidate for the prevention of tuberculosis.